These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 16644633

  • 1. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?
    Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.
    Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC.
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
    Cottrell DA.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794
    [Abstract] [Full Text] [Related]

  • 8. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.
    Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, Nishimura S, Kondo M, Nanjo K.
    Diabetologia; 1991 Feb; 34(2):129-32. PubMed ID: 2065848
    [Abstract] [Full Text] [Related]

  • 9. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T, Kubo K, Oki C, Nakano Y, Okai K, Sanke T, Nanjo K.
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S, Hietaniemi K, Kiviluoto T, Timonen T, Yki-Järvinen H.
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [Abstract] [Full Text] [Related]

  • 12. Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery.
    Stadler M, Krššák M, Jankovic D, Göbl C, Winhofer Y, Pacini G, Bischof M, Haidinger M, Saemann M, Mühlbacher F, Korbonits M, Baumgartner-Parzer SM, Luger A, Prager R, Anderwald CH, Krebs M.
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):208-13. PubMed ID: 23302039
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.
    Mäkimattila S, Fineman MS, Yki-Järvinen H.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2822-7. PubMed ID: 10946889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.